Exelixis Inc (EXEL) Stock Price, Quote, News & History

EXELNASDAQ
$54.45
-0.81-1.47%
At close: Aug 28, 5:00 PM EST
$54.00
-0.45-0.83%
After Hours: Aug 28, 6:24 PM EST
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
1.18B
Investing Cash Flow (TTM)
93.01M
Financing Cash Flow (TTM)
-1.16B
Free Cash Flow (TTM)
1.16B
Capital Expenditure (TTM)
-25.24M
Net Change in Cash (TTM)
117.02M

Analyst Trends and Forecast

2
2
May
0
0
0
0
Jun
1
4
Jul
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
2.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$12.81B
PE Ratio (TTM)
17.37
PE Ratio (FWD)
17.42
PEG Ratio (TTM)
-
PS Ratio (TTM)
6.13
PB Ratio (TTM)
7.42
Earnings Yield % (TTM)
5.76%
Earnings Yield % (FWD)
5.74%
EV / EBITDA (TTM)
12.75
Price / EBITDA (TTM)
14.64
Price / Free Cash Flow (TTM)
12.90
Book Value / Share
$7.44

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$281.45M
Debt to Equity
0.09
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$55.14
Close
$54.45
Volume / Avg.
1.49M / 2.61M
Day Range
$54.12 - $55.25
52 Wk Range
33.76 - 57.57
Market Cap
$13.72B
P/E Ratio
17.37
Dividend Yield
-
Exchange
NASDAQ
RSI
49
Short Interest
14.95%
Days to Cover
8.71

About

Sector
Health Care
Industry
Biotechnology
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and f...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Exelixis (EXEL) stock?

A

You can purchase shares of Exelixis (NASDAQ:EXEL) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Exelixis (EXEL) stock?

A

Exelixis has a consensus price target of $47.93.

Q

What is the current price for Exelixis (EXEL)?

A

The stock price for Exelixis (NASDAQ: EXEL) is $54 last updated August 28, 2026 at 6:24 PM EDT.

Q

Does Exelixis (EXEL) pay a dividend?

A

There are no upcoming dividends for Exelixis.

Q

When is Exelixis (NASDAQ:EXEL) reporting earnings?

A

Exelixis does not have any upcoming earnings scheduled.

Q

Is Exelixis (EXEL) going to split?

A

There is no upcoming split for Exelixis.

Q

What sector and industry does Exelixis (EXEL) operate in?

A

Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.